Albumin Market Size (USD 8.95 Billion by 2030) Achieves Record-breaking Growth in Meeting Healthcare Requirements

Allied Market Research has published a study report with the title Albumin Market Size was Valued at 𝐔𝐒𝐃 𝟒.𝟖𝟏 𝐁𝐢𝐥𝐥𝐢𝐨𝐧 𝐢𝐧 𝟐𝟎𝟐𝟎, and is Anticipated to Garner 𝐔𝐒𝐃 𝟖.𝟗𝟓 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐛𝐲 𝟐𝟎𝟑𝟎, registering a 𝐂𝐀𝐆𝐑 𝐨𝐟 𝟔.𝟒% from 2021 to 2030. The report provides an extensive analysis of changing market dynamics, major segments, value chain, competitive scenario, and regional landscape. This research offers a valuable guidance to leading players, investors, shareholders, and startups in devising strategies for sustainable growth and gaining competitive edge in the market.

Albumin is globular protein found in blood plasma. It is most abundant protein in plasma constituting around 50% of the total protein in the blood. It plays a vital role in maintaining proper oncotic blood pressure and transporting hormones, fatty acids, and other compounds throughout the body. It is derived from blood plasma on fractionation, and is widely used to clinically treat variety of diseases. Different types of albumin are used clinically, including human serum albumin, bovine serum albumin, and recombinant albumin.

𝐈𝐦𝐩𝐚𝐜𝐭 𝐨𝐟 𝐂𝐎𝐕𝐈𝐃-𝟏𝟗 𝐨𝐧 𝐀𝐥𝐛𝐮𝐦𝐢𝐧 𝐌𝐚𝐫𝐤𝐞𝐭-

• Increasing use of albumin for the production of vaccines such as Covaxin and Covishield for the treatment of COVID-19 infections has impacted the global albumin market positively.
• Persistent innovations by prominent players and growing number of product approvals have again been beneficial for the industry.

𝐆𝐞𝐭 𝐒𝐚𝐦𝐩𝐥𝐞 𝐏𝐃𝐅 𝐑𝐞𝐩𝐨𝐫𝐭 𝐰𝐢𝐭𝐡 𝐆𝐫𝐚𝐩𝐡𝐬 𝐚𝐧𝐝 𝐅𝐢𝐠𝐮𝐫𝐞𝐬 𝐇𝐞𝐫𝐞: https://www.alliedmarketresearch.com/request-sample/2583

𝐖𝐡𝐚𝐭 𝐚𝐫𝐞 𝐭𝐡𝐞 𝐟𝐚𝐜𝐭𝐨𝐫𝐬 𝐝𝐫𝐢𝐯𝐢𝐧𝐠 𝐭𝐡𝐞 𝐀𝐥𝐛𝐮𝐦𝐢𝐧 𝐌𝐚𝐫𝐤𝐞𝐭?

Significant surge in non-therapeutic application of albumin, increasing production of immunoglobulins & plasma collection, and growth in the development of plant-based albumin are expected to drive the growth of the global albumin market. On the other hand, stringent regulations imposed by several government bodies on the adoption of albumin products impede the growth to some extent. However, increase in the number of cancer surgeries that lead to cause hypoalbuminemia is expected to create lucrative opportunities in the industry.

𝐓𝐨𝐩 𝐀𝐥𝐛𝐮𝐦𝐢𝐧 𝐂𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬

• Takeda Pharmaceuticals Inc
• Thermo Fisher Scientific
• Ventria Bioscience
• Baxter International Inc.
• China Biologic Products, Inc.
• Merck KGaA
• Novozymes
• Octapharma AG
• CSL Limited
• Grifols, S.A.

𝐀𝐥𝐛𝐮𝐦𝐢𝐧 𝐌𝐚𝐫𝐤𝐞𝐭 𝐒𝐞𝐠𝐦𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧: -

The global albumin market is analysed across type, application and region.

By type, the human serum albumin segment held the largest share in 2020, garnering around two-third of the total market. This segment is also expected to cite the fastest CAGR of 6.8% during the forecast period.

By application, the therapeutics segment generated the highest market share in 2020, accounting nearly two-fifths of the global market. This segment would also exhibit the fastest CAGR of 6.7% during the forecast period.

By region, the market across North America held the lion's share in 2020, garnering nearly half of the global market. The Asia-Pacific region, on the other hand, is expected to cite the fastest CAGR of 7.7% during the forecast period.

𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞 𝐭𝐡𝐞 𝐑𝐞𝐩𝐨𝐫𝐭: https://www.alliedmarketresearch.com/purchase-enquiry/2583

Key Findings of The Study

• By type, the human serum albumin segment was the highest contributor to the market in 2020.
• On the basis of application type, the therapeutics segment dominated the market in 2020, and is expected to continue this trend during the forecast period.
• Region-wise, North America garnered the largest revenue share in 2020, whereas Asia-Pacific is anticipated to grow at the highest CAGR during the forecast period.

Our Market Research Solution Provides You Answer to Below Mentioned Question:

• Which are the driving factors responsible for the growth of market?
• Which are the roadblock factors of this market?
• What are the new opportunities, by which market will grow in coming years?
• What are the trends of this market?
• Which are main factors responsible for new product launch?
• How big is the global & regional market in terms of revenue, sales and production?
• How far will the market grow in forecast period in terms of revenue, sales and production?
• Which region is dominating the global market and what are the market shares of each region in the overall market in 2022?
• How will each segment grow over the forecast period and how much revenue will these segments account for in 2030?
• Which region has more opportunities?

By Region Outlook

• North America
(U.S., Canada, Mexico)
• Europe
(Germany, France, UK, Italy, Spain, Rest of Europe)
• Asia-Pacific
(Japan, China, India, Rest of Asia-Pacific)
• LAMEA
(Brazil, Saudi Arabia, South Africa, Rest of LAMEA)

Contact Details:

David Correa
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
help@alliedmarketresearch.com

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

This release was published on openPR.